Walleye Capital’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$20.6M Buy
364,246
+141,779
+64% +$8.27M 0.13% 188
2025
Q4
$13.2M Buy
222,467
+150,655
+210% +$8.2M 0.08% 479
2025
Q3
$3.89M Buy
71,812
+71,746
+108,706% +$4.1M 0.03% 1089
2025
Q2
$3.63K Sell
66
-32,705
-100% -$1.93M ﹤0.01% 4367
2025
Q1
$2.32M Buy
32,771
+4,699
+17% +$316K 0.03% 1311
2024
Q4
$1.85M Sell
28,072
-127,370
-82% -$8.53M 0.02% 1855
2024
Q3
$10.9M Buy
155,442
+117,119
+306% +$9.79M 0.12% 640
2024
Q2
$3.16M Buy
38,323
+3,639
+10% +$303K 0.03% 1683
2024
Q1
$3.03M Buy
34,684
+22,111
+176% +$1.98M 0.03% 1687
2023
Q4
$1.21M Buy
12,573
+7,572
+151% +$670K 0.02% 2194
2023
Q3
$442K Sell
5,001
-43,638
-90% -$3.88M 0.01% 2907
2023
Q2
$4.22M Sell
48,639
-88,633
-65% -$8.34M 0.07% 843
2023
Q1
$13.3M Buy
137,272
+71,798
+110% +$7.44M 0.27% 97
2022
Q4
$6.78M Sell
65,474
-27,272
-29% -$2.56M 0.15% 205
2022
Q3
$7.86M Buy
92,746
+52,496
+130% +$4.67M 0.18% 147
2022
Q2
$3.34M Sell
40,250
-75,399
-65% -$6M 0.1% 243
2022
Q1
$8.92M Buy
115,649
+104,154
+906% +$8.71M 0.26% 87
2021
Q4
$1.02M Buy
+11,495
New +$949K 0.03% 584
2021
Q3
Sell
-3,560
Closed -$297 1602
2021
Q2
$297 Buy
+3,560
New +$282K 0.01% 944
2020
Q1
Hold
0
1000
2019
Q4
Hold
0
1848
2019
Q3
Hold
0
1968
2019
Q2
Sell
-822
Closed -$70.3K 1784
2019
Q1
$73K Buy
+822
New +$76.2K 0.11% 1116

Other funds holding BMRN